TickerFactsScreenerDevelopers

Cue Biopharma, Inc. (CUE) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $20.80M2019: $44.29M2020: $74.87M2021: $64.37M2022: $51.61M2023: $48.51M2024: $22.46M2025: $27.14M$27.14M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$27.14M+20.8%
2024$22.46M-53.7%
2023$48.51M-6.0%
2022$51.61M-19.8%
2021$64.37M-14.0%
2020$74.87M+69.0%
2019$44.29M+112.9%
2018$20.80M—